These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. miRNA biomarkers in renal disease. Franczyk B; Gluba-Brzózka A; Olszewski R; Parolczyk M; Rysz-Górzyńska M; Rysz J Int Urol Nephrol; 2022 Mar; 54(3):575-588. PubMed ID: 34228259 [TBL] [Abstract][Full Text] [Related]
5. Preventive Strategies for Vascular Calcification in Patients with Chronic Kidney Disease. Shigematsu T; Sonou T; Ohya M; Yokoyama K; Yoshida H; Yokoo T; Okuda K; Masumoto AR; Iwashita Y; Iseki K; Kunimoto S; Yamano Y Contrib Nephrol; 2017; 189():169-177. PubMed ID: 27951564 [TBL] [Abstract][Full Text] [Related]
6. MicroRNAs 223-3p and 93-5p in patients with chronic kidney disease before and after renal transplantation. Ulbing M; Kirsch AH; Leber B; Lemesch S; Münzker J; Schweighofer N; Hofer D; Trummer O; Rosenkranz AR; Müller H; Eller K; Stadlbauer V; Obermayer-Pietsch B Bone; 2017 Feb; 95():115-123. PubMed ID: 27866993 [TBL] [Abstract][Full Text] [Related]
7. Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study. Brigant B; Metzinger-Le Meuth V; Massy ZA; McKay N; Liabeuf S; Pelletier M; Sallée M; M'Baya-Moutoula E; Paul P; Drueke TB; Burtey S; Metzinger L Clin Kidney J; 2017 Feb; 10(1):30-37. PubMed ID: 28643818 [TBL] [Abstract][Full Text] [Related]
8. Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease. Zoccali C; London G Nephrol Dial Transplant; 2015 Mar; 30(3):352-7. PubMed ID: 25712936 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High Phosphorus. Panizo S; Naves-Díaz M; Carrillo-López N; Martínez-Arias L; Fernández-Martín JL; Ruiz-Torres MP; Cannata-Andía JB; Rodríguez I J Am Soc Nephrol; 2016 Mar; 27(3):824-34. PubMed ID: 26187577 [TBL] [Abstract][Full Text] [Related]
10. Identification of differentially expressed miRNAs associated with chronic kidney disease-mineral bone disorder. Kim KI; Jeong S; Han N; Oh JM; Oh KH; Kim IW Front Med; 2017 Sep; 11(3):378-385. PubMed ID: 28623542 [TBL] [Abstract][Full Text] [Related]
11. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD. Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-92a Mediates Endothelial Dysfunction in CKD. Shang F; Wang SC; Hsu CY; Miao Y; Martin M; Yin Y; Wu CC; Wang YT; Wu G; Chien S; Huang HD; Tarng DC; Shiu YT; Cheung AK; Huang PH; Chen Z; Shyy JY J Am Soc Nephrol; 2017 Nov; 28(11):3251-3261. PubMed ID: 28696247 [TBL] [Abstract][Full Text] [Related]
14. microRNAs are dysregulated in the cerebral microvasculature of CKD mice. Metzinger-Le Meuth V; Andrianome S; Chillon JM; Bengrine A; Massy ZA; Metzinger L Front Biosci (Elite Ed); 2014 Jan; 6(1):80-8. PubMed ID: 24389144 [TBL] [Abstract][Full Text] [Related]
15. Identification of miR-16 as an endogenous reference gene for the normalization of urinary exosomal miRNA expression data from CKD patients. Lange T; Stracke S; Rettig R; Lendeckel U; Kuhn J; Schlüter R; Rippe V; Endlich K; Endlich N PLoS One; 2017; 12(8):e0183435. PubMed ID: 28859135 [TBL] [Abstract][Full Text] [Related]
16. New mechanisms involved in the development of cardiovascular disease in chronic kidney disease. Figuer A; Alique M; Valera G; Serroukh N; Ceprían N; de Sequera P; Morales E; Carracedo J; Ramírez R; Bodega G Nefrologia (Engl Ed); 2023; 43(1):63-80. PubMed ID: 37268501 [TBL] [Abstract][Full Text] [Related]